Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $337.86 | $7.17 | 4,609.83% | 6,757.20x | 237.75x | 7.49x | 9.06x | 18.20x | $529.27M | 1.42% | $4.13B | 37.48 | $35.29B | 110.97 | ||
| CORT | CORCEPT THERAPEUTICS INC | $83.67 | $29.72 | 181.54% | 83.67x | 81.87x | 11.69x | 13.93x | 1.30x | $162.57M | 1.88% | $631.90M | 6.10 | $8.68B | 131.60 | ||
| NVO | NOVO NORDISK A S | $47.57 | $143.51 | -66.85% | 13.23x | 2.00x | 4.35x | 8.07x | 0.14x | $9.34B | 4.42% | $26.18B | 5.89 | $222.03B | 8.95 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $473.29 | $29.83 | 1,486.78% | 1,526.74x | 252.80x | 19.38x | 267.34x | 6.26x | $221.36M | 0.36% | $233.89M | 1.78 | $64.25B | 422.91 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.60 | $11.79 | -27.05% | 17.92x | 6.59x | 5.70x | 3.64x | 0.35x | -$23.64M | -4.92% | $133.17M | 2.38 | $492.44M | 7.33 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $40.59 | $15.00 | 170.62% | 82.84x | 40.68x | 5.07x | 5.75x | 1.24x | $101.73M | 3.36% | $535.38M | 7.17 | $2.91B | 54.34 | ||
| GMAB | GENMAB A | $31.68 | $109.58 | -71.09% | 13.52x | 1.76x | 5.71x | 3.54x | 0.12x | $1.19B | 5.87% | $5.75B | 8.96 | $18.72B | 9.36 | ||
| ARGX | ARGENX SE | $921.80 | $279.87 | 229.37% | 36.84x | 51.24x | 29,735.48x | 7.85x | 2.54x | $467.72M | 0.83% | $7.17B | 117.50 | $53.86B | 66.39 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $193.03 | $65.42 | 195.08% | 83.56x | 25.04x | 15.04x | 4.00x | 1.38x | $30.76M | 0.81% | $950.17M | 48.53 | $4.11B | 39.91 | ||
| VCEL | VERICEL CORP | $37.39 | $6.70 | 458.07% | 143.81x | 136.41x | 7.30x | 5.88x | 2.67x | $20.38M | 1.08% | $321.86M | 6.38 | $1.89B | 64.43 | ||
| TECH | BIO-TECHNE CORP | $63.82 | $16.52 | 286.40% | 127.64x | 31.56x | 8.15x | 5.06x | 1.74x | $224.06M | 2.26% | $1.97B | 12.65 | $10.19B | 46.15 | ||
| RPRX | ROYALTY PHARMA PLC | $39.60 | $42.73 | -7.32% | 22.50x | 8.23x | 7.28x | 2.38x | 0.45x | $2.11B | 12.35% | $9.62B | 22.28 | $30.87B | 29.56 | ||
| KRYS | KRYSTAL BIOTECH INC | $217.46 | $68.29 | 218.46% | 31.52x | 34.81x | 16.87x | 5.54x | 2.86x | $166.02M | 2.64% | $1.14B | 39.30 | $5.92B | 30.64 | ||
| VCYT | VERACYTE INC | $47.75 | $9.31 | 413.16% | 122.44x | 91.20x | 7.59x | 3.00x | 2.52x | $98.21M | 2.61% | $1.26B | 15.98 | $3.50B | 61.37 | ||
| CRMD | CORMEDIX INC | $10.32 | $13.36 | -22.77% | 4.55x | 4.12x | 3.66x | 2.17x | 23.65x | $74.42M | 9.50% | $374.13M | 4.93 | $913.53M | 8.14 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.75 | $1.31 | 33.26% | 25.00x | 69.17x | 2.24x | 2.66x | 0.72x | -$11.69M | -8.40% | $52.91M | 0.67 | $135.27M | 15.25 | ||
| HALO | HALOZYME THERAPEUTICS INC | $64.66 | $75.84 | -14.74% | 13.22x | 10.10x | 6.10x | 15.09x | 0.51x | $602.40M | 7.95% | $503.92M | 4.30 | $8.69B | 10.28 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.91 | $7.81 | 90.87% | 25.71x | 19.65x | 7.39x | 5.37x | 1.25x | $119.87M | 6.10% | $365.77M | 2.78 | $1.97B | 19.04 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.31 | $42.24 | 28.59% | 19.97x | 18.36x | 3.37x | 1.72x | 0.76x | $832.13M | 7.98% | $6.06B | 31.54 | $9.78B | 12.66 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.64 | $0.76 | 904.39% | 109.14x | 49.93x | 6.47x | 7.22x | 8.01x | $3.05M | 0.45% | $101.92M | 1.12 | $696.75M | 52.67 | ||
| EXEL | EXELIXIS INC | $44.01 | $29.45 | 49.45% | 17.89x | 17.02x | 5.16x | 5.46x | 1.08x | $779.77M | 6.60% | $2.16B | 8.05 | $11.60B | 12.51 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $463.13 | $171.29 | 170.38% | 32.36x | 24.79x | 10.10x | 6.78x | 1.95x | $3.34B | 2.82% | $17.32B | 67.76 | $114.40B | 24.54 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.00 | $37.17 | -0.45% | 11.46x | 11.35x | 2.58x | 2.55x | 0.75x | $296.89M | 13.94% | $835.12M | 14.51 | $1.65B | 6.13 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.53 | $3.35 | 94.93% | 24.19x | 35.18x | 4.18x | 7.37x | 1.36x | $21.15M | 4.06% | $70.68M | 0.89 | $459.90M | 20.27 | ||
| MNKD | MANNKIND CORP | $5.59 | $1.45 | 286.23% | 55.90x | 70.23x | 5.46x | -38.53x | 2.39x | $43.39M | 2.52% | -$44.55M | -0.15 | $1.95B | 26.63 | ||
| INCY | INCYTE CORP | $101.50 | $68.57 | 48.03% | 16.80x | 14.54x | 4.13x | 4.28x | 1.13x | $1.20B | 6.03% | $4.65B | 23.77 | $17.51B | 10.40 | ||
| INVA | INNOVIVA INC | $20.86 | $15.51 | 34.48% | 11.04x | 9.74x | 3.71x | 1.54x | 1.71x | $196.54M | 13.64% | $1.01B | 14.63 | $1.34B | 6.24 | ||
| ADMA | ADMA BIOLOGICS INC | $19.72 | $9.43 | 109.01% | 22.41x | 32.95x | 9.63x | 10.88x | 1.69x | $40.73M | 0.87% | $431.19M | 1.81 | $4.71B | 27.34 | ||
| UTHR | UNITED THERAPEUTICS CORP | $480.96 | $201.73 | 138.42% | 16.89x | 17.42x | 6.73x | 3.14x | 4.94x | $1.12B | 5.33% | $6.59B | 150.46 | $19.37B | 10.92 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.10 | $12.81 | 80.38% | 12.91x | 14.71x | 4.90x | 3.09x | 3.57x | $234.54M | 8.28% | $920.25M | 7.51 | $2.15B | 6.64 | ||
| MDXG | MIMEDX GROUP INC | $6.96 | $2.80 | 148.77% | 24.86x | 16.25x | 2.62x | 4.31x | 2.21x | $66.82M | 6.48% | $238.95M | 1.61 | $906.92M | 13.10 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $723.67 | $361.61 | 100.13% | 16.66x | 16.47x | 5.26x | 2.46x | 2.46x | $4.22B | 5.63% | $30.96B | 298.82 | $76.26B | 13.35 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.